Asked by: Bell Ribeiro-Addy (Labour - Streatham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.2 of the report entitled A comparison of the care of Asian and White women who have experienced a stillbirth or neonatal death, published by the MBRRACE-UK Perinatal Confidential Enquiry on 14 December 2023, whether her Department has had discussions with NHS England on taking steps to improve how ethnicity data is recorded.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department has regular and ongoing discussions with NHS England, and other relevant bodies, on improving neonatal and maternity data quality. This includes discussions on how to improve the recording of ethnicity data. NHS Equity and Equality Guidance, produced as part of NHS England’s three-year delivery plan for maternity and neonatal services, includes ethnic coding data completeness to better understand local populations and their health outcomes. Ethnic coding data completeness has improved year on year, from 85% in 2019 to 93% in 2022.
Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with relevant stakeholders on tackling shortages of Ezetimibe.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department is aware of supply issues affecting several Ezetimibe suppliers. We are engaging with these suppliers to address the issues, and are working with alternative suppliers to ensure supplies remain available.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to improve retention rates of NHS maternity staff.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan sets out how to improve culture and leadership, to ensure that up to 130,000 fewer staff leave the National Health Service over the next 15 years. This includes: implementing actions from the NHS People Plan that have been shown to be successful; implementing plans to improve flexible opportunities for prospective retirees, and delivering the actions needed to modernise the NHS pension scheme; and committing to ongoing national funding for continuing professional development for nurses, midwives, and allied health professionals, so NHS staff are supported to meet their full potential. These measures apply across staff groups, including maternity staff.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the number and proportion of NHS providers that have adopted two stage shared decision-making across all admitted pathways.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In May 2023, NHS England published guidance setting out five core perioperative care requirements relating to the care of adult patients awaiting planned inpatient surgery. One of these requirements is that patients must be involved in shared decision making regarding admitted pathways. NHS England does not collect data on the number of National Health Service providers that have adopted two stage shared decision making across all admitted pathways. NHS England’s published guidance is available at the following link:
Asked by: Grahame Morris (Labour - Easington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the medication reimbursement mechanism for community pharmacists.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors’ payments, and where they have been overpaid, we decrease payments.
Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of medication costs on community pharmacies.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors’ payments, and where they have been overpaid, we decrease payments.
Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of offering one-off payments to dentists that agree to work in under-served areas on the morale of other dentists.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
We want to encourage all professionals to commit more of their time to National Health Service work, and to work in areas of the country with low provision of NHS dental care. That is why we are introducing Golden Hellos, as set out in our plan to reform and recover NHS dentistry. A golden hello of £20,000 will be offered per dentist, for a total of up to 240 dentists. The Golden Hellos will support practices in areas where recruitment is particularly challenging and make a real difference to those patients needing dental care.
Asked by: Thérèse Coffey (Conservative - Suffolk Coastal)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve access to mental health services in Suffolk Coastal constituency.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The National Health Service forecasts that, between 2018/19 and 2023/24, spending on mental health services has increased by £4.7 billion in cash terms, compared to the target of £3.4 billion set out at the time of the NHS Long Term Plan. All integrated care boards are also on track to meet the Mental Health Investment Standard in 2023/24.
Almost £16 billion was invested in mental health in 2022/23, enabling over 3.5 million people, including in the Suffolk Coastal constituency, to be in contact with mental health services, a 10% increase on the previous year.
Asked by: Emily Thornberry (Labour - Islington South and Finsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the contract awarded by her Department to Ethypharm UK Ltd on 27 January 2022 for the storage and management of the Department's Naloxone buffer stock, how many packs of Naloxone were distributed from the buffer stock for use by patients in the UK in the (a) 2021-22, (b) 2022-23, and (c) 2023-24 financial year.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of capacity in district nursing on the timeliness of patient discharge from hospital in 2023.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.